Claire Simons - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Claire Simons - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2002	1
2003	2
2004	5
2005	5
2006	4
2007	2
2008	2
2009	1
2010	5
2011	5
2012	4
2014	3
2015	2
2016	2
2017	6
2018	2
2019	5
2020	5
2021	5
2022	7
2023	4
2024	0

70 results

Page of 7

Results by year

Page 1

Long-Term Outcomes of Eladocagene Exuparvovec Compared with Standard of Care in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Modelling Study.

Simons CL, Hwu WL, Zhang R, Simons MJHG, Bergkvist M, Bennison C. Simons CL, et al. Adv Ther. 2023 Dec;40(12):5399-5414. doi: 10.1007/s12325-023-02689-6. Epub 2023 Oct 6. Adv Ther. 2023. PMID: 37803205 Free PMC article.

Exploring Proteus mirabilis Methionine tRNA Synthetase Active Site: Homology Model Construction, Molecular Dynamics, Pharmacophore and Docking Validation.

Elbaramawi SS, Eissa AG, Noureldin NA, Simons C. Elbaramawi SS, et al. Among authors: simons c. Pharmaceuticals (Basel). 2023 Sep 6;16(9):1263. doi: 10.3390/ph16091263. Pharmaceuticals (Basel). 2023. PMID: 37765071 Free PMC article.

Targeting Mycobacterium tuberculosis: Synthesis, in vitro and in silico evaluation of novel N¹ -(benzo[d]oxazol-2-yl)-N⁴ -arylidine compounds.

Zawal AG, Abdel-Aziz MM, El-Shanawani AA, Abdel-Aziz LM, Taha M, Simons C, Elbaramawi SS. Zawal AG, et al. Among authors: simons c. Arch Pharm (Weinheim). 2023 Aug;356(8):e2300187. doi: 10.1002/ardp.202300187. Epub 2023 Jun 6. Arch Pharm (Weinheim). 2023. PMID: 37279375

Pyridine based dual binding site aromatase (CYP19A1) inhibitors.

Eissa AG, Powell LE, Gee J, Foster PA, Simons C. Eissa AG, et al. Among authors: simons c. RSC Med Chem. 2023 Jan 3;14(2):356-366. doi: 10.1039/d2md00352j. eCollection 2023 Feb 22. RSC Med Chem. 2023. PMID: 36846364 Free PMC article.

Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors.

Alshabani LA, Kumar A, Willcocks SJ, Srithiran G, Bhakta S, Estrada DF, Simons C. Alshabani LA, et al. Among authors: simons c. RSC Med Chem. 2022 Aug 16;13(11):1350-1360. doi: 10.1039/d2md00155a. eCollection 2022 Nov 16. RSC Med Chem. 2022. PMID: 36426236 Free PMC article.

4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitors.

Eissa AG, Barrow D, Gee J, Powell LE, Foster PA, Simons C. Eissa AG, et al. Among authors: simons c. Eur J Med Chem. 2022 Oct 5;240:114569. doi: 10.1016/j.ejmech.2022.114569. Epub 2022 Jul 6. Eur J Med Chem. 2022. PMID: 35834906 Free article.

Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England.

Petersohn S, Salles G, Wang M, Wu J, Wade SW, Simons CL, Bennison C, Siddiqi R, Peng W, Kloos I, Castaigne G, Hess G. Petersohn S, et al. Among authors: simons cl. J Med Econ. 2022 Jan-Dec;25(1):730-740. doi: 10.1080/13696998.2022.2079317. J Med Econ. 2022. PMID: 35611697 Free article.

Phenylalanyl tRNA synthetase (PheRS) substrate mimics: design, synthesis, molecular dynamics and antimicrobial evaluation.

Noureldin NA, Richards J, Kothayer H, Baraka MM, Eladl SM, Wootton M, Simons C. Noureldin NA, et al. Among authors: simons c. RSC Adv. 2022 Jan 20;12(4):2511-2524. doi: 10.1039/d1ra06439h. eCollection 2022 Jan 12. RSC Adv. 2022. PMID: 35425259 Free PMC article.

Synthesis, computational study and biological evaluation of 9-acridinyl and 1-coumarinyl-1,2,3-triazole-4-yl derivatives as topoisomerase II inhibitors.

Abdel-Hafez GA, Mohamed AI, Youssef AF, Simons C, Aboraia AS. Abdel-Hafez GA, et al. Among authors: simons c. J Enzyme Inhib Med Chem. 2022 Dec;37(1):502-513. doi: 10.1080/14756366.2021.2021898. J Enzyme Inhib Med Chem. 2022. PMID: 35012398 Free PMC article.

Correction to: An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making Approach.

Piena MA, Kroep S, Simons C, Fenwick E, Harty GT, Wong SL, van Hout BA. Piena MA, et al. Among authors: simons c. Adv Ther. 2022 Feb;39(2):909. doi: 10.1007/s12325-021-02032-x. Adv Ther. 2022. PMID: 34997918 Free PMC article. No abstract available.

70 results

Page of 7

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year